The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Abstract
Background— Extent and severity of myocardial ischemia are determinants of risk for patients with coronary artery disease, and ischemia reduction is an important therapeutic goal. The Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) nuclear substudy compared the effectiveness of percutaneous coronary intervention (PCI) for ischemia reduction added to optimal medical therapy (OMT) with the use of myocardial perfusion single photon emission computed tomography (MPS). Methods and Results— Of the 2287 COURAGE patients, 314 were enrolled in this substudy of serial rest/stress MPS performed before treatment and 6 to 18 months (mean=374±50 days) after randomization using paired exercise (n=84) or vasodilator stress (n=230). A blinded core laboratory analyzed quantitative MPS measures of percent ischemic myocardium. Moderate to severe ischemia encumbered ≥10% myocardium. The primary end point was ≥5% reduction in ischemic myocardium at follow-up. Treatment groups had similar baseline characteristics. At follow-up, the reduction in ischemic myocardium was greater with PCI+OMT (−2.7%; 95% confidence interval, −1.7%, −3.8%) than with OMT (−0.5%; 95% confidence interval, −1.6%, 0.6%; P <0.0001). More PCI+OMT patients exhibited significant ischemia reduction (33% versus 19%; P =0.0004), especially patients with moderate to severe pretreatment ischemia (78% versus 52%; P =0.007). Patients with ischemia reduction had lower unadjusted risk for death or myocardial infarction ( P =0.037 [risk-adjusted P =0.26]), particularly if baseline ischemia was moderate to severe ( P =0.001 [risk-adjusted P =0.08]). Death or myocardial infarction rates ranged from 0% to 39% for patients with no residual ischemia to ≥10% residual ischemia on follow-up MPS ( P =0.002 [risk-adjusted P =0.09]). Conclusions— In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone. Our findings suggest a treatment target of ≥5% ischemia reduction with OMT with or without coronary revascularization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Self-citationHachamovitch, R., Hayes, S. W., Friedman, J. D., Cohen, I., & Berman, D. S. (2003) · Circulation · doi:10.1161/01.cir.0000072790.23090.41 · Cited by 1,563
Self-citationAutomatic quantification of ejection fraction from gated myocardial perfusion SPECT.
Germano, G., Kiat, H., Kavanagh, P., Moriel, M., Mazzanti, M., Su, H.-T., Train, K. F. V., & Berman, D. S. (1995) · PubMed · Cited by 1,239
Self-citationHachamovitch, R., Berman, D. S., Shaw, L. J., Kiat, H., Cohen, I., Cabico, J. A., Friedman, J., & Diamond, G. A. (1998) · Circulation · doi:10.1161/01.cir.97.6.535 · Cited by 1,221
Self-citationHachamovitch, R., Berman, D. S., Kiat, H., Cohen, I., Cabico, J. A., Friedman, J., & Diamond, G. A. (1996) · Circulation · doi:10.1161/01.cir.93.5.905 · Cited by 836
Self-citationShaw, L. J., Hachamovitch, R., Berman, D. S., Marwick, T. H., Lauer, M. S., Heller, G. V., Iskandrian, A. E., Kesler, K. L., Travin, M. I., Lewin, H. C., et al. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00606-8 · Cited by 353
Self-citationAutomated quantification of myocardial perfusion SPECT using simplified normal limits
Slomka, P. J., Nishina, H., Berman, D. S., Akincioglu, C., Abidov, A., Friedman, J. D., Hayes, S. W., & Germano, G. (2005) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2004.10.006 · Cited by 299
Self-citationBerman, D. S., Abidov, A., Kang, X., Hayes, S. W., Friedman, J. D., Sciammarella, M. G., Cohen, I., Gerlach, J., Waechter, P. B., Germano, G., et al. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2004.03.033 · Cited by 280
Self-citationTask force 1. Pathogenesis of coronary disease: The biologic role of risk factors
Fuster, V., Gotto, A. M., Libby, P., Loscalzo, J., & McGill, H. C. (1996) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(96)00014-9 · Cited by 186
Cholesterol reduction yields clinical benefits: meta-analysis including recent trials
Gould, A. L., Davies, G., Alemao, E., Yin, D., & Cook, J. R. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.05.012 · Cited by 170
Mahmarian, J. J., Dakik, H. A., Filipchuk, N. G., Shaw, L. J., Iskander, S., Ruddy, T. D., Keng, F. Y. J., Henzlova, M. J., Allam, A. H., Moyé, L. A., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.07.068 · Cited by 140
Self-citationSchwartz, R. G., Pearson, T. A., Kalaria, V. G., Mackin, M. L., Williford, D. J., Awasthi, A., Shah, A. H., Rains, A. B., & Guido, J. J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00767-8 · Cited by 70
Self-citationParisi, A. F., Hartigan, P. M., & Folland, E. D. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00293-3 · Cited by 68
Self-citationMostaza, J. M., Gomez, M. V., Gallardo, F. G., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00529-x · Cited by 55
Shaw, L. J., Heller, G. V., Casperson, P. R., Miranda-Peats, R., Slomka, P. J., Friedman, J. D., Hayes, S. W., Schwartz, R. G., Weintraub, W. S., Maron, D. J., et al. (2006) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2006.06.134 · Cited by 37
Self-citationBerman, D. S., Kang, X., Schisterman, E. F., Gerlach, J., Kavanagh, P., Areeda, J. S., Sharir, T., Hayes, S. W., Shaw, L. J., Lewin, H. C., et al. (2001) · Journal of Nuclear Cardiology · doi:10.1067/mnc.2001.113991 · Cited by 35
Self-citation
Cited by
2018 ESC/EACTS guidelines on myocardial revascularization
Neumann, F.-J., Sousa-Uva, M., Ahlsson, A., Alfonso, F., Banning, A. P., Benedetto, U., Byrne, R. A., Collet, J.-P., Falk, V., Head, S. J., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy394 · Cited by 7,167
2013 ESC guidelines on the management of stable coronary artery disease
Task Force Members, Montalescot, G., Sechtem, U., Achenbach, S., Andreotti, F., Arden, C., Budaj, A., Bugiardini, R., Crea, F., Cuisset, T., et al. (2013) · European Heart Journal · doi:10.1093/eurheartj/eht296 · Cited by 4,510
(2014) · European Heart Journal · doi:10.1093/eurheartj/ehu278 · Cited by 4,314
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
Tonino, P. A. L., De Bruyne, B., Pijls, N. H. J., Siebert, U., Ikeno, F., van `t Veer, M., Klauss, V., Manoharan, G., Engstrøm, T., Oldroyd, K. G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0807611 · Cited by 4,260
2014 ESC/EACTS Guidelines on myocardial revascularization
Kolh, P., Windecker, S., Alfonso, F., Collet, J.-P., Cremer, J., Falk, V., Filippatos, G., Hamm, C., Head, S. J., Jüni, P., et al. (2014) · European Journal of Cardio-Thoracic Surgery · doi:10.1093/ejcts/ezu366 · Cited by 4,199
Metadata
- Authors
- Shaw, L. J., Berman, D. S., Maron, D. J., Mancini, G. B. J., Hayes, S. W., Hartigan, P. M., Weintraub, W. S., O’Rourke, R. A., Dada, M., Spertus, J. A., Chaitman, B. R., Friedman, J., Slomka, P., Heller, G. V., Germano, G., Gosselin, G., Berger, P., Kostuk, W. J., Schwartz, R. G., Knudtson, M., Veledar, E., Bates, E. R., McCallister, B., Teo, K. K., & Boden, W. E.
- Venue
- Circulation
- Published
- 2008-03-11
- Volume
- 117
- Issue
- 10
- Pages
- 1283-1291
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2125741545
- Cited by
- 1,605
- References
- 16
- FWCI
- 108.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.